News

All news

2019-10-11

ACCORD HEALTHCARE LAUNCH PRASUGREL

Accord Healthcare is delighted to announce the launch of Prasugrel Accord 10 mg which is available in a pack size of 28 tablets.  

This medicine, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI]) undergoing primary or delayed percutaneous coronary intervention (PCI).

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC is available here, or from www.hpra.ie. 

 

All news